Information about the Falsified Medicines Directive (FMD)

Marketing authorisation holders including parallel importers who market prescription-only medicinal products in the Netherlands should contribute to the development and maintenance of the NMVS. After 9 February 2019, no products may be released for the market without the features on the packaging. It is also mandatory to upload product information on the European Hub when the products are released.

  • For more information, registration and financial contribution, please visit the NMVO website (in Dutch).
  • For more information about registering products on the European Hub, please visit the EMVO website.


Category:Pharma, Packaging, Classification and Labelling, Regulatory


Related News